Interleukin-12 requires initial CD80-mediated T-cell activation to support immune responses toward human breast and ovarian carcinoma
- 1 May 1999
- journal article
- Published by Springer Nature in Cancer Gene Therapy
- Vol. 6 (3) , 228-237
- https://doi.org/10.1038/sj.cgt.7700050
Abstract
Cancer Gene Therapy is the essential gene therapy resource for cancer researchers and clinicians, keeping readers up to date with the latest developments in gene therapy for cancer.Keywords
This publication has 0 references indexed in Scilit: